InDex Pharmaceuticals’ investor call at 15:00 CET on June 1
Proteomics Market worth $72.9 billion
InventHelp Inventor Develops Hands-Free Scratching Accessory (LAX-1526)
Sun Pharma et Philogen concluent un accord exclusif de distribution, de licence et d’approvisionnement pour la commercialisation de la spécialité NIDLEGY™ en Europe, en Australie et en Nouvelle-Zélande USA – Français USA – English USA – English APAC – English USA – español USA – Deutsch
Experimental Decoy Protects Against SARS-CoV-2 Infection
America’s Best Wings: Everything You Need to Know
Ariège: “Caregivers minimize the workload that this represents”. a first forum to support caregivers
VIDEO. Toulouse: around thirty demonstrators demanded the maintenance of the La Grave Medical Center which closed
World No Tobacco Day: five gentle (and sometimes unusual) methods to avoid falling back
Cardiovascular health, breathing, fatigue… What do we gain by quitting smoking?
Montauban hospital has set up two treatment programs to fight against obesity
STOCKHOLM, May 31, 2023 /PRNewswire/ — InDex Pharmaceuticals Holding AB (publ) will hold an investor call in light of today’s press release announcing the company’s license...
